BPA Call 36C24925A0031-36C24926N0263
Award Date 12/20/25
Potential Completion Date 12/19/29
Potential Value $2.4M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
East Hanover, NJ 07936, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Advanced Accelerator Applications USA Inc., a Novartis subsidiary specializing in radiopharmaceutical manufacturing, received a $896,106.33 firm fixed-price Blanket Purchase Agreement (BPA) call award from the Department of Veterans Affairs' Veterans Integrated Service Network 10 on October 1, 2024. The contract, which is not set-aside for small businesses, covers the supply of PLUVICTO (lutetium Lu 177 vipivotide tetraxetan), an advanced nuclear medicine product used for targeted radioligand...
- Advanced Accelerator Applications USA Inc., a Novartis subsidiary specializing in radiopharmaceutical manufacturing, was awarded a $1.14M firm fixed-price blanket purchase agreement (BPA) call by the Department of Veterans Affairs' Veterans Integrated Service Network 15 on February 17, 2024. The contract covers the supply of PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) and LUTATHERA (lutetium Lu 177 dotatate), advanced nuclear medicine products used for targeted radioligand therapy and...
- Advanced Accelerator Applications USA Inc., a Novartis subsidiary specializing in radiopharmaceutical manufacturing, received a $166,145.70 firm fixed price Blanket Purchase Agreement (BPA) call for PLUVICTO (lutetium Lu 177 vipivotide tetraxetan) on March 28, 2025. This extension contract, which completes July 31, 2025, was awarded by Veterans Integrated Service Network 15 without a small business set-aside designation and will be performed in Millburn, New Jersey. PLUVICTO is an advanced...
- This is a federal contract award to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract, valued at $779,095.44, is a Blanket Purchase Agreement (BPA) call under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with the Department of Veterans Affairs (VA). The contract is for the delivery of the radiopharmaceutical products PLUVICTO and LUTATHERA, which are used in cancer...
- This federal contract award was issued by the Veterans Integrated Service Network 9 (VISN 9), a civilian agency within the U.S. Department of Veterans Affairs (VA), to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $498,437.10 firm fixed-price contract is for the PLUVICTO drug, a radiopharmaceutical used in cancer treatment and diagnostic imaging. The contract is a Blanket Purchase Agreement (BPA)...
- The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) call contract to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract, with a total ceiling value of $993,272.70, is for the supply of Lutetium Lu 177 PLUVICTO 27mCi/mL, a radiopharmaceutical used for cancer treatment. This BPA call is under the parent Master GSA Schedule for Pharmaceuticals and Drugs...
- This is a Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) to Advanced Accelerator Applications USA Inc., a subsidiary of Novartis and a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract, with a ceiling value of $977,749.98, is for the delivery of PLUVICTO doses in Calendar Year 2024. This order falls under the parent GSA Schedule 61-IB, Pharmaceuticals and Drugs, and is priced on a Firm...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $349,600 firm fixed price delivery order to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is for the provision of radiopharmaceutical products such as Lutetium Lu 177 Dotatate, Lutetium Lu 177 Vipivotide Tetraxetan, gallium Ga 68 dotatate, and Ga-68 Dotatate injections to VA medical centers and...
- Advanced Accelerator Applications USA Inc., a Novartis subsidiary specializing in radiopharmaceutical and nuclear medicine products, has been awarded a delivery order by Veterans Integrated Service Network 12 for the purchase of medication on an as-needed basis over an eight-month period. The contract, effective January 1, 2025, through August 31, 2025, carries a ceiling value of $631,353.66 and is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). This delivery...
- This federal contract award is for a Blanket Purchase Agreement (BPA) call with Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is being administered by the Veterans Integrated Service Network 2, a civilian agency within the Department of Veterans Affairs (VA). The award is for the radiopharmaceutical product PLUVICTO (lutetium Lu 177 vipivotide tetraxetan), which is used for cancer...